The m6A methyltransferase METTL3 modifies PGC-1α mRNA promoting mitochondrial dysfunction and oxLDL-induced inflammation in monocytes
Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved..
Mitochondrial biogenesis and energy metabolism are essential for regulating the inflammatory state of monocytes. This state is partially controlled by peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), a coactivator that regulates mitochondrial biogenesis and energy metabolism. Disruption of these processes can also contribute to the initiation of chronic inflammatory diseases, such as pulmonary fibrosis, atherosclerosis, and rheumatoid arthritis. Methyltransferase-like 3 (METTL3)-dependent N6-methyladenosine (m6A) methylation has recently been shown to regulate a variety of inflammatory processes. However, the role of m6A mRNA methylation in affecting mitochondrial metabolism in monocytes under inflammation is unclear, nor is there an established relationship between m6A methylation and PGC-1α. In this study, we identified a novel mechanism by which METTL3 acts during oxidized low-density lipoprotein (oxLDL)-induced monocyte inflammation, where METTL3 and YTH N6-methyladenosine RNA binding protein 2 (YTHDF2) cooperatively modify PGC-1α mRNA, mediating its degradation, decreasing PGC-1α protein levels, and thereby enhancing the inflammatory response. METTL3 coordinated with YTHDF2 to suppress the expression of PGC-1α, as well as that of cytochrome c (CYCS) and NADH:ubiquinone oxidoreductase subunit C2 (NDUFC2) and reduced ATP production and oxygen consumption rate (OCR). This subsequently increased the accumulation of cellular and mitochondrial reactive oxygen species (ROS) and the levels of proinflammatory cytokines in inflammatory monocytes. These data may provide new insights into the role of METTL3-dependent m6A modification of PGC-1α mRNA in the monocyte inflammation response. These data also contribute to a more comprehensive understanding of the pathogenesis of monocyte-macrophage inflammation-associated diseases, such as pulmonary fibrosis, atherosclerosis, and rheumatoid arthritis.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2021 |
---|---|
Erschienen: |
2021 |
Enthalten in: |
Zur Gesamtaufnahme - volume:297 |
---|---|
Enthalten in: |
The Journal of biological chemistry - 297(2021), 3 vom: 15. Sept., Seite 101058 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Zhang, Xinning [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 08.12.2021 Date Revised 14.12.2021 published: Print-Electronic Citation Status MEDLINE |
---|
doi: |
10.1016/j.jbc.2021.101058 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM32919660X |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM32919660X | ||
003 | DE-627 | ||
005 | 20231225204607.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2021 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1016/j.jbc.2021.101058 |2 doi | |
028 | 5 | 2 | |a pubmed24n1097.xml |
035 | |a (DE-627)NLM32919660X | ||
035 | |a (NLM)34375639 | ||
035 | |a (PII)S0021-9258(21)00860-7 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Zhang, Xinning |e verfasserin |4 aut | |
245 | 1 | 4 | |a The m6A methyltransferase METTL3 modifies PGC-1α mRNA promoting mitochondrial dysfunction and oxLDL-induced inflammation in monocytes |
264 | 1 | |c 2021 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 08.12.2021 | ||
500 | |a Date Revised 14.12.2021 | ||
500 | |a published: Print-Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a Copyright © 2021 The Authors. Published by Elsevier Inc. All rights reserved. | ||
520 | |a Mitochondrial biogenesis and energy metabolism are essential for regulating the inflammatory state of monocytes. This state is partially controlled by peroxisome proliferator-activated receptor gamma coactivator 1-alpha (PGC-1α), a coactivator that regulates mitochondrial biogenesis and energy metabolism. Disruption of these processes can also contribute to the initiation of chronic inflammatory diseases, such as pulmonary fibrosis, atherosclerosis, and rheumatoid arthritis. Methyltransferase-like 3 (METTL3)-dependent N6-methyladenosine (m6A) methylation has recently been shown to regulate a variety of inflammatory processes. However, the role of m6A mRNA methylation in affecting mitochondrial metabolism in monocytes under inflammation is unclear, nor is there an established relationship between m6A methylation and PGC-1α. In this study, we identified a novel mechanism by which METTL3 acts during oxidized low-density lipoprotein (oxLDL)-induced monocyte inflammation, where METTL3 and YTH N6-methyladenosine RNA binding protein 2 (YTHDF2) cooperatively modify PGC-1α mRNA, mediating its degradation, decreasing PGC-1α protein levels, and thereby enhancing the inflammatory response. METTL3 coordinated with YTHDF2 to suppress the expression of PGC-1α, as well as that of cytochrome c (CYCS) and NADH:ubiquinone oxidoreductase subunit C2 (NDUFC2) and reduced ATP production and oxygen consumption rate (OCR). This subsequently increased the accumulation of cellular and mitochondrial reactive oxygen species (ROS) and the levels of proinflammatory cytokines in inflammatory monocytes. These data may provide new insights into the role of METTL3-dependent m6A modification of PGC-1α mRNA in the monocyte inflammation response. These data also contribute to a more comprehensive understanding of the pathogenesis of monocyte-macrophage inflammation-associated diseases, such as pulmonary fibrosis, atherosclerosis, and rheumatoid arthritis | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 4 | |a METTL3 | |
650 | 4 | |a PGC-1α | |
650 | 4 | |a RNA methylation | |
650 | 4 | |a inflammation | |
650 | 4 | |a m(6)A modification | |
650 | 4 | |a mitochondria | |
650 | 4 | |a monocytes | |
650 | 4 | |a post-transcriptional regulation | |
650 | 7 | |a Lipoproteins, LDL |2 NLM | |
650 | 7 | |a NDUFC2 protein, human |2 NLM | |
650 | 7 | |a PPARGC1A protein, human |2 NLM | |
650 | 7 | |a Peroxisome Proliferator-Activated Receptor Gamma Coactivator 1-alpha |2 NLM | |
650 | 7 | |a RNA, Messenger |2 NLM | |
650 | 7 | |a RNA-Binding Proteins |2 NLM | |
650 | 7 | |a Reactive Oxygen Species |2 NLM | |
650 | 7 | |a YTHDF2 protein, human |2 NLM | |
650 | 7 | |a oxidized low density lipoprotein |2 NLM | |
650 | 7 | |a Methyltransferases |2 NLM | |
650 | 7 | |a EC 2.1.1.- |2 NLM | |
650 | 7 | |a METTL3 protein, human |2 NLM | |
650 | 7 | |a EC 2.1.1.62 |2 NLM | |
650 | 7 | |a Electron Transport Complex I |2 NLM | |
650 | 7 | |a EC 7.1.1.2 |2 NLM | |
700 | 1 | |a Li, Xin |e verfasserin |4 aut | |
700 | 1 | |a Jia, Hongti |e verfasserin |4 aut | |
700 | 1 | |a An, Guoshun |e verfasserin |4 aut | |
700 | 1 | |a Ni, Juhua |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t The Journal of biological chemistry |d 1945 |g 297(2021), 3 vom: 15. Sept., Seite 101058 |w (DE-627)NLM000004995 |x 1083-351X |7 nnns |
773 | 1 | 8 | |g volume:297 |g year:2021 |g number:3 |g day:15 |g month:09 |g pages:101058 |
856 | 4 | 0 | |u http://dx.doi.org/10.1016/j.jbc.2021.101058 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 297 |j 2021 |e 3 |b 15 |c 09 |h 101058 |